Venoms and Toxins
Title:Meet Our Editorial Board Member
Volume: 1
Author(s): Carmela Fimognari
Affiliation:
Export Options
About this article
Cite this article as:
Fimognari Carmela , Meet Our Editorial Board Member, Venoms and Toxins 2021; 1 (1) : e240321192452 . https://dx.doi.org/10.2174/266612170101210324160217
DOI https://dx.doi.org/10.2174/266612170101210324160217 |
Print ISSN 2666-1217 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-1225 |
Article Metrics
Related Articles
-
Exploiting Significance of Physical Exercise in Prevention of Gastrointestinal Disorders
Current Pharmaceutical Design Emerging Role of ImmunoPET in Receptor Targeted Cancer Therapy
Current Drug Delivery Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways
Current Pharmaceutical Design Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond
Current Cancer Drug Targets Enhancing Endothelial Progenitor Cell Function Through Selective Estrogen Receptor Modulation: A Potential Approach to Cardiovascular Risk Reduction
Cardiovascular & Hematological Agents in Medicinal Chemistry The Metabolite Trimethylamine-N-Oxide is an Emergent Biomarker of Human Health
Current Medicinal Chemistry Thymoquinone: Major Molecular Targets, Prominent Pharmacological Actions and Drug Delivery Concerns
Current Bioactive Compounds Mutant Cell Surface Receptors as Targets for Individualized Cancer Diagnosis and Therapy
Current Cancer Drug Targets Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine From Presenilinase to γ-Secretase, Cleave to Capacitate
Current Alzheimer Research Supplementation, Optimal Status, and Analytical Determination of Vitamin D: Where are we Standing in 2012?
Anti-Cancer Agents in Medicinal Chemistry Feasibility of Increased Navy Bean Powder Consumption for Primary and Secondary Colorectal Cancer Prevention
Current Nutrition & Food Science Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology Cellular Regulation of SIRT1
Current Pharmaceutical Design ZD6474, a Small Molecule Tyrosine Kinase Inhibitor, Potentiates the Anti-Tumor and Anti-Metastasis Effects of Radiation for Human Nasopharyngeal Carcinoma
Current Cancer Drug Targets Mucin-based Targeted Pancreatic Cancer Therapy
Current Pharmaceutical Design Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications
Current Drug Targets Oxidative Stress Modulation Through Habitual Physical Activity
Current Pharmaceutical Design The Role of Heat Shock Proteins in Cisplatin Resistance
Anti-Cancer Agents in Medicinal Chemistry